ACSL3 and metabolic dysfunction-associated steatotic liver disease: This work examined the GSEA database and clinical samples, demonstrating that ACSL3 is markedly overexpressed in NAFLD and HCC tissues, with a positive correlation to disease severity (Li et al., 2024).